Fredrick Hagemeister

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “A phase 1/2 study of lenalidomide and obinutuzumab with CHOP for newly diagnosed DLBCL”.

A phase 1/2 study of lenalidomide and obinutuzumab with CHOP for newly diagnosed DLBCL

Blood Advances(2022)10.1182/bloodadvances.2022008174

N/A

0.629DataRank · unranked

15 citations

Stefan Alig, Yasuhiro Oki, Loretta J. Nastoupil, Luis Fayad, Sattva S. Neelapu +16 more

Aggressive B-cell Lymphoma with MYC/TP53 Dual Alterations Displays Distinct Clinicopathobiological Features and Response to Novel Targeted Agents

Molecular Cancer Research(2020)10.1158/1541-7786.mcr-20-0466

N/A

0DataRank · unranked

38 citations

Zijun Y. Xu‐Monette, Lan V. Pham, Xudong Wang, Alexandar Tzankov, Xiaosheng Fang +23 more